Literature DB >> 10949828

Evaluation of natural killer cell activity.

J H Cox, M deSouza.   

Abstract

Natural killer (NK) cells are being appreciated not only for their ability to recognize and lyse tumor cells and virus-infected cells but also for their immunoregulatory properties. NK cells provide a first line of defense against invading pathogens with a two pronged attack, lysis of infected cells and secretion of cytokines and chemokines with potent antipathogen effects. This article describes the standard chromium release assay, which measures the ability of NK cells derived from the peripheral blood to lyse appropriate target cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10949828     DOI: 10.1385/MB:15:2:147

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  24 in total

Review 1.  Control of infections by NK cells.

Authors:  C H Tay; E Szomolanyi-Tsuda; R M Welsh
Journal:  Curr Top Microbiol Immunol       Date:  1998       Impact factor: 4.291

2.  Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus.

Authors:  G Rappocciolo; J F Toso; D J Torpey; P Gupta; C R Rinaldo
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

Review 4.  Pathogenesis of the natural killer cell deficiency in AIDS.

Authors:  M C Sirianni; F Tagliaferri; F Aiuti
Journal:  Immunol Today       Date:  1990-03

5.  Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.

Authors:  P F Hu; L E Hultin; P Hultin; M A Hausner; K Hirji; A Jewett; B Bonavida; R Detels; J V Giorgi
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-11-01

6.  Differentiation of human NK cells into NK1 and NK2 subsets.

Authors:  D Peritt; S Robertson; G Gri; L Showe; M Aste-Amezaga; G Trinchieri
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

7.  Measurement of direct and indirect forms of anti-HIV-1 ADCC: implications for other retroviral disease.

Authors:  K J Weinhold; D S Tyler; H K Lyerly
Journal:  Dev Biol Stand       Date:  1990

8.  Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.

Authors:  A Oliva; A L Kinter; M Vaccarezza; A Rubbert; A Catanzaro; S Moir; J Monaco; L Ehler; S Mizell; R Jackson; Y Li; J W Romano; A S Fauci
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

9.  Natural killer activity from normal peripheral blood lymphocytes against a human T lymphotropic retrovirus type III (HTLV-III)-infected cell line.

Authors:  M C Sirianni; G De Sanctis; B Macchi; S Soddu; F Ensoli; F Aiuti; L Fontana
Journal:  Diagn Clin Immunol       Date:  1988

10.  Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence.

Authors:  K Blomberg; C Granberg; I Hemmilä; T Lövgren
Journal:  J Immunol Methods       Date:  1986-02-12       Impact factor: 2.303

View more
  1 in total

1.  Transplantation of β-endorphin neurons into the hypothalamus promotes immune function and restricts the growth and metastasis of mammary carcinoma.

Authors:  Dipak K Sarkar; Changqing Zhang; Sengottuvelan Murugan; Madhavi Dokur; Nadka I Boyadjieva; Maria Ortigüela; Kenneth R Reuhl; Sepide Mojtehedzadeh
Journal:  Cancer Res       Date:  2011-08-11       Impact factor: 12.701

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.